Literature DB >> 15737702

Absence of causative mutations and presence of autism-related allele in FOXP2 in Japanese autistic patients.

Hong Li1, Takanori Yamagata, Masato Mori, Mariko Y Momoi.   

Abstract

We analyzed the FOXP2 gene, which encodes a putative transcription factor containing a polyglutamine tract and a forkhead DNA-binding domain, for a possible causative mutation in autism. FOXP2 was reported to be mutated in patients with a severe speech and language disorder. FOXP2 was located on chromosome 7q31, which is one of the loci involved in autism. Autism and specific language impairment share some of their clinical phenotypes. In addition, FOXP2 was expressed abundantly in the brain. We screened all of the exons of FOXP2 for causative mutations in 53 Japanese autistic patients using denaturing high-performance liquid chromatography and direct sequencing. A delCAA in exon 5 causing one glutamine deletion in the first polyglutamine tract was detected in four patients and in 2 of 50 control individuals. The frequency of the TT allele with the G to T base change in intron 15 was significantly high in the autistic population. The other base changes included one silent base change (A569G) in exon 5 and three in introns. Our results may suggest a relationship between autism and the FOXP2 gene or a gene located nearby.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15737702     DOI: 10.1016/j.braindev.2004.06.002

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  14 in total

1.  ASD-relevant Animal Models of the Foxp Family of Transcription Factors.

Authors:  J Michael Bowers; Genevieve Konopka
Journal:  Autism Open Access       Date:  2012-12-05

2.  What can time-frequency and phase coherence measures tell us about the genetic basis of P3 amplitude?

Authors:  Stephen M Malone; Matt McGue; William G Iacono
Journal:  Int J Psychophysiol       Date:  2016-11-19       Impact factor: 2.997

3.  Phenotype of FOXP2 haploinsufficiency in a mother and son.

Authors:  Gregory M Rice; Gordana Raca; Kathy J Jakielski; Jennifer J Laffin; Christina M Iyama-Kurtycz; Sigan L Hartley; Rae E Sprague; Anne T Heintzelman; Lawrence D Shriberg
Journal:  Am J Med Genet A       Date:  2011-11-21       Impact factor: 2.802

4.  Single nucleotide polymorphisms predict symptom severity of autism spectrum disorder.

Authors:  Yun Jiao; Rong Chen; Xiaoyan Ke; Lu Cheng; Kangkang Chu; Zuhong Lu; Edward H Herskovits
Journal:  J Autism Dev Disord       Date:  2012-06

5.  Altered ultrasonic vocalization in mice with a disruption in the Foxp2 gene.

Authors:  Weiguo Shu; Julie Y Cho; Yuhui Jiang; Minhua Zhang; Donald Weisz; Gregory A Elder; James Schmeidler; Rita De Gasperi; Miguel A Gama Sosa; Donald Rabidou; Anthony C Santucci; Daniel Perl; Edward Morrisey; Joseph D Buxbaum
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-27       Impact factor: 11.205

6.  Ultrasonic vocalization impairment of Foxp2 (R552H) knockin mice related to speech-language disorder and abnormality of Purkinje cells.

Authors:  Eriko Fujita; Yuko Tanabe; Akira Shiota; Masatsugu Ueda; Kiyotaka Suwa; Mariko Y Momoi; Takashi Momoi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

Review 7.  Genetic advances in the study of speech and language disorders.

Authors:  D F Newbury; A P Monaco
Journal:  Neuron       Date:  2010-10-21       Impact factor: 17.173

Review 8.  Autism, Mitochondria and Polybrominated Diphenyl Ether Exposure.

Authors:  Sarah Wong; Cecilia Giulivi
Journal:  CNS Neurol Disord Drug Targets       Date:  2016       Impact factor: 4.388

Review 9.  FOXP transcription factors in vertebrate brain development, function, and disorders.

Authors:  Marissa Co; Ashley G Anderson; Genevieve Konopka
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2020-01-30

Review 10.  Evolution of the Human Brain Can Help Determine Pathophysiology of Neurodevelopmental Disorders.

Authors:  Koichiro Irie; Miyuki Doi; Noriyoshi Usui; Shoichi Shimada
Journal:  Front Neurosci       Date:  2022-04-01       Impact factor: 5.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.